ZIVO Bioscience to Present at the Q3 Virtual Investor Summit

In this article:

Keego Harbor, Michigan--(Newsfile Corp. - August 11, 2021) - ZIVO Bioscience (NASDAQ: ZIVO) today announced that Andrew Dahl will be attending the Q3 Virtual Investor Summit.

 Event

 Q3 Investor Summit

 Date

 August 17-18th, 2021

 Presentation

 August 17th at 9:30am ET

 Location

 https://zoom.us/webinar/register/WN__vMWv9xxRxGzIdpz-1p3Ew

 

About ZIVO Bioscience

ZIVO Bioscience, Inc. (NASDAQ: ZIVO), is a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional bioproduct candidates originally derived from proprietary algal cultures.

For further information:

ZIVO Bioscience
Christine Rich
248-452-9866
crich@zivobioscience.com

About the Investor Summit

The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 80+ companies and over 800 investors, consisting of institutional investors, family offices, and private wealth.

To request complimentary investor registration: please click here: Complimentary Investor Registration

Contact:

Sasha Murray at sasha@investorsummitgroup.com

Advertisement